Please ensure Javascript is enabled for purposes of website accessibility
Home / Products / Antibody / Recombinant Antibody

Anti-CD220/INSR Antibody (R2Z58)

Catalog #:   RHC19101 Specific References (35) DATASHEET
Host species: Mouse
Isotype: IgG2a
Applications: ELISA, FCM
Accession: P06213
Overview

Catalog No.

RHC19101

Species reactivity

Human

Host species

Mouse

Isotype

IgG2a

Clonality

Monoclonal

Tested applications

ELISA: 1:10000, FCM: 1:200-1:400

Target

INSR, IR, CD220, Insulin receptor

Concentration

1 mg/ml

Endotoxin level

Please contact with the lab for this information.

Purity

>95% as determined by SDS-PAGE.

Purification

Protein A/G purified from cell culture supernatant.

Accession

P06213

Applications

ELISA, FCM

Form

Liquid

Storage buffer

0.01M PBS, pH 7.4, 0.05% Sodium Azide.

Stability and Storage

Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C short term (1-2 weeks). Store at -20°C 12 months. Store at -80°C long term.

Clone ID

R2Z58

Data Image
  • Flow Cytometry
    Flow cytometric analysis of Jurkat cells using CD220 mouse mAb (green) and negative control (red).
References

M2‑like tumour‑associated macrophage‑secreted IGF promotes thyroid cancer stemness and metastasis by activating the PI3K/AKT/mTOR pathway., PMID:34184083

Rare causes of hypoglycemia in adults., PMID:32409005

The expression of the insulin receptor in gastric cancer correlates with the HER2 status and may have putative therapeutic implications., PMID:30989432

Glucose-Sensitive Myokine/Cardiokine MG53 Regulates Systemic Insulin Response and Metabolic Homeostasis., PMID:30586741

Oncofoetal insulin receptor isoform A marks the tumour endothelium; an underestimated pathway during tumour angiogenesis and angiostatic treatment., PMID:30559346

Combined Immunosuppressive Therapy Induces Remission in Patients With Severe Type B Insulin Resistance: A Prospective Cohort Study., PMID:30201849

Evaluation of anti-insulin receptor antibodies as potential novel therapies for human insulin receptoropathy using cell culture models., PMID:29700562

Delivery of Biologics Across the Blood-Brain Barrier with Molecular Trojan Horse Technology., PMID:29067674

Detection of Islet Cell Immune Reactivity with Low Glycemic Index Foods: Is This a Concern for Type 1 Diabetes?, PMID:28819632

Brain and Organ Uptake in the Rhesus Monkey in Vivo of Recombinant Iduronidase Compared to an Insulin Receptor Antibody-Iduronidase Fusion Protein., PMID:28279069

Diabetic Ketoacidosis Without Diabetes., PMID:27636019

Ridaforolimus (MK-8669) synergizes with Dalotuzumab (MK-0646) in hormone-sensitive breast cancer., PMID:27765027

Re-engineering therapeutic antibodies for Alzheimer's disease as blood-brain barrier penetrating bi-specific antibodies., PMID:27572805

Systematic Population Screening, Using Biomarkers and Genetic Testing, Identifies 2.5% of the U.K. Pediatric Diabetes Population With Monogenic Diabetes., PMID:27271189

Type B insulin resistance syndrome., PMID:27254267

A Novel Allosteric Insulin Receptor-Activating Antibody Reduces Hyperglycemia without Hypoglycemia in Diabetic Cynomolgus Monkeys., PMID:26578267

Insulin treatment promotes tyrosine phosphorylation of PKR and inhibits polyIC induced PKR threonine phosphorylation., PMID:26321373

Intrinsic Resistance to Cixutumumab Is Conferred by Distinct Isoforms of the Insulin Receptor., PMID:26263910

Insulin family polymorphisms in pregnancies complicated by small for gestational age infants., PMID:26089371

Successful pregnancy outcomes in a patient with type A insulin resistance syndrome., PMID:25472847

Insulin receptor antibody-iduronate 2-sulfatase fusion protein: pharmacokinetics, anti-drug antibody, and safety pharmacology in Rhesus monkeys., PMID:24889100

Insulin and metabolic stress stimulate multisite serine/threonine phosphorylation of insulin receptor substrate 1 and inhibit tyrosine phosphorylation., PMID:24652289

Improved glucose metabolism in vitro and in vivo by an allosteric monoclonal antibody that increases insulin receptor binding affinity., PMID:24533136

Insulin receptor (IR) and insulin-like growth factor receptor 1 (IGF-1R) signaling systems: novel treatment strategies for cancer., PMID:24338270

Pharmacokinetics and brain uptake in the rhesus monkey of a fusion protein of arylsulfatase a and a monoclonal antibody against the human insulin receptor., PMID:23192358

Circulating insulin-like growth factors may contribute substantially to insulin receptor isoform A and insulin receptor isoform B signalling., PMID:22982059

Correlation between gene expression of IGF-1R pathway markers and cetuximab benefit in metastatic colorectal cancer., PMID:22294722

Reengineering biopharmaceuticals for targeted delivery across the blood-brain barrier., PMID:22230573

Altered expression of insulin receptor isoforms in breast cancer., PMID:22046260

Biologic TNFα-inhibitors that cross the human blood-brain barrier., PMID:21327054

Selective targeting of a TNFR decoy receptor pharmaceutical to the primate brain as a receptor-specific IgG fusion protein., PMID:20100527

A modified protocol for efficient DNA encapsulation into pegylated immunoliposomes (PILs)., PMID:19545595

Antibody-mediated targeting of siRNA via the human insulin receptor using avidin-biotin technology., PMID:19093871

N-linked glycans of the human insulin receptor and their distribution over the crystal structure., PMID:17957771

Decline in exogenous gene expression in primate brain following intravenous administration is due to plasmid degradation., PMID:16779704

Datasheet
$ 220
Product specifications
50 μg 220 100 μg 350

Contact Information

Order: order@antibodysystem.com

Mail: support@antibodysystem.com

Distributor list

For research use only. Not for human or drug use.

Need help with your order?

Find out more about placing an order here

Anti-CD220/INSR Antibody (R2Z58) [RHC19101]
Terms of sale Website terms of use Cookie policy Privacy
Copyright © 2025 AntibodySystem SAS. All Rights Reserved.            All Products are for Research Use Only